Horizon Discovery is a world-leader in the application of gene editing and gene modulation technologies and is at the centre of innovation and drug discovery.

 

Background

  • High science story with ongoing requirement for education of stakeholders
  • Transformational acquisition of GE Healthcare Dharmacon, Inc. for $85 million
  • Raised £80 million in an over-subscribed placing bringing in new significant US shareholders and US analyst coverage

 

Our strategy

  • Work in partnership with management to develop an international IR and profile raising strategy to build knowledge and awareness
  • Simplify the story, outline achievable milestones and make the news impactful
  • Target international media to profile the Horizon investment case as the Company delivers on strategy

23,000+

catalogue products and related research services in over 50 countries

 

Outcome

  • Clear announcements and media coverage, including tips by the Sunday Times’ Business Editor and the Financial Times, have had a positive impact on the share price with clear and well understood messages